SCHEMBL1368482

SCHEMBL1368482

O=C(NCCc1ccc(Cl)cc1)c1ccc(O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 1.00
RAB9A P51151 4/20 1.00
CYP2D6 P10635 2/20 1.00
GAA P10253 2/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
MAPT P10636 2/20 1.00
CYP1A2 P05177 1/20 1.00
CYP2C19 P33261 1/20 1.00
GFER P55789 1/20 1.00
MCHR1 Q99705 4/20 0.69
ESRRG P62508 3/20 0.68
ESRRB O95718 2/20 0.68
KMT2A Q03164 3/20 0.63
MEN1 O00255 2/20 0.63
CHRM1 P11229 1/20 0.61
HTR2A P28223 1/20 0.61
ALDH1A1 P00352 1/20 0.60
FABP2 P12104 1/20 0.60
PPARG P37231 1/20 0.60
PPARD Q03181 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8668493 1.00 NPC1 (1.00) NPC1RAB9ACYP2D6GAASMN1; SMN2
SCHEMBL11707941 0.95 CYP2D6 (0.91) NPC1RAB9ACYP2D6GAASMN1; SMN2
SCHEMBL3875042 0.95 CYP2D6 (0.91) NPC1RAB9ACYP2D6GAASMN1; SMN2
SCHEMBL31420450 0.92 NPC1 (0.84) NPC1RAB9ACYP2D6GAASMN1; SMN2
SCHEMBL27731636 0.91 NPC1 (0.83) NPC1RAB9ACYP2D6GAASMN1; SMN2
SCHEMBL2987921 0.86 NPC1 (0.75) NPC1RAB9ACYP2D6GAASMN1; SMN2
SCHEMBL1570073 0.86 NPC1 (0.75) NPC1RAB9ACYP2D6GAASMN1; SMN2
SCHEMBL1367702 0.86 NPC1 (0.75) NPC1RAB9ACYP2D6GAASMN1; SMN2
SCHEMBL96062 0.86 NPC1 (0.75) NPC1RAB9ACYP2D6GAASMN1; SMN2
SCHEMBL27842419 0.86 NPC1 (0.75) NPC1RAB9ACYP2D6GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3144303-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES Array Biopharma, Inc. (US) 2017-03-22 EP disclosed
US-9556139-B2 6-substituted phenoxychroman carboxylic acid derivatives ARRAY BIOPHARMA INC. (US) 2017-01-31 US disclosed
EP-2826774-B1 Intermediates for 6-substituted phenoxychroman carboxylic acid derivatives ARRAY BIOPHARMA INC (US) 2016-05-25 EP disclosed
US-20150232442-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2015-08-20 US disclosed
US-9096567-B2 6-substituted phenoxychroman carboxylic acid derivatives ARRAY BIOPHARMA INC. (US) 2015-08-04 US disclosed
CN-103450138-B Preparation of intermidiates of 6-substituted phenoxychroman carboxylic acid derivatives ARRAY BIOPHARMA INC 2015-04-08 CN disclosed
EP-2826774-A1 Intermediates for 6-substituted phenoxychroman carboxylic acid derivatives Array Biopharma, Inc. (US) 2015-01-21 EP disclosed
EP-2307397-B1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2014-08-20 EP disclosed
US-20140221342-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2014-08-07 US disclosed
US-8716498-B2 6-substituted phenoxychroman carboxylic acid derivatives ARRAY BIOPHARMA, INC. (US) 2014-05-06 US disclosed
US-20110288293-A1 ISOQUINOLINE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-11-24 US disclosed
EP-2377851-A1 ISOQUINOLINE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2011-10-19 EP disclosed
CN-102131794-A 6-substituted phenoxy chroman carboxylic acid derivatives ARRAY BIOPHARMA INC 2011-07-20 CN disclosed
US-20110105463-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2011-05-05 US disclosed
EP-2307397-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES Array Biopharma, Inc. (US) 2011-04-13 EP disclosed
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2010-07-08 US disclosed
WO-2009158426-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2009-12-30 WO disclosed
CN-101553461-A 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC (US) 2009-10-07 CN disclosed
EP-2057115-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES Array Biopharma, Inc. (US) 2009-05-13 EP disclosed
WO-2008024746-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA, INC. (US) 2008-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110288293-A1 ISOQUINOLINE DERIVATIVE HRH1, HRH2, HRH4 NPC1 161/4885RAB9A 1548/4885CYP2D6 2247/4885
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 NPC1 3905/4885RAB9A 622/4885CYP2D6 585/4885
US-20140221342-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES HRH1, HRH2, HRH4 NPC1 3178/4885RAB9A 128/4885CYP2D6 210/4885
US-20110105463-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES GPR52, CD22, CD4 NPC1 3822/4885RAB9A 755/4885CYP2D6 172/4885
US-20150232442-A1 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES GPR52, CD22, CD74 NPC1 3720/4885RAB9A 720/4885CYP2D6 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.